通过膜介导的策略,有效地在细胞内传递生物药物
Donghyeok Gang1, Yeonju Song1, Yeonjin Ko1
1Chemical & Biological Integrative Research Center, Korea Institute of Science and Technology, 5 Hwarang-ro 14-gil, Seongbuk-gu, Seoul 02792, Republic of Korea.
Methods (San Diego, Calif.)
|October 31, 2025
概括
小分子药物面临着局限性,而生物药物无法进入细胞. 本综述探讨了基于膜的载体,用于有效的细胞内生物传递,以准许多疾病机制.
科学领域:
- 生物技术是生物技术.
- 药物运输 药物运输 药物运输
- 分子生物学分子生物学
背景情况:
- 小分子药物占目前治疗药物的80%左右,但需要特定的结合条件.
- 生物药物具有更广泛的结合能力,但由于膜不透性,它们仅限于细胞外点.
- 细胞内点的数量明显高于细胞外点,这凸显了细胞内生物输送的必要性.
研究的目的:
- 审查用于细胞内生物输送的基于膜的载体的生成和应用.
- 根据模式对这些载体进行分类,以提高治疗效用.
- 解决将生物物质送到细胞内点的关键需求.
主要方法:
- 讨论细胞衍生的囊泡作为基于膜的载体.
- 基于人造膜的载体的探索.
- 根据治疗方式对载体实例的分类.
主要成果:
- 基于膜的载体,包括细胞衍生和人工类型,显示出细胞内传递的前景.
- 按模式分类有助于理解和增强治疗应用.
- 克服细胞膜障碍是释放生物制剂潜力的关键.
结论:
- 生物药物的细胞内输送对于治疗基本疾病机制至关重要.
- 基于膜的载体代表了一种可行的策略,以提高生物制剂的治疗疗效.
- 这些载体的进一步开发和应用可以扩大细胞内点的治疗选择.
相关概念视频
Cellular Membranes and Drug Transport
1.4K
Drugs must traverse multiple biological barriers, such as multi-layered skin, single-layered intestinal epithelium, and the plasma membrane, to reach their target sites within the body. The plasma membrane, a highly structured composite of phospholipids, carbohydrates, and proteins, is the cell's protective boundary, facilitating selective substance exchange.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
1.4K
Mechanisms of Drug Absorption: Paracellular, Transcellular, and Vesicular Transport
1.6K
Drugs need to permeate cell membranes to reach their target sites after administration. Orally administered drugs must transcend intestinal epithelial membrane barriers to infiltrate the systemic circulation. Drugs with a molecular weight of less than 500 Daltons diffuse through gaps between neighboring cells, called paracellular pathways.
However, most drugs use the transcellular route, traversing directly through the cell membranes via two mechanisms: passive and active transport. Passive...
However, most drugs use the transcellular route, traversing directly through the cell membranes via two mechanisms: passive and active transport. Passive...
1.6K
Bioavailability Enhancement: Drug Permeability Enhancement
182
Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
182
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
165
Body:Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug...
165
Drug Delivery: Overview
714
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
714
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
188
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
188


